Biao Xing is currently the Executive Director of Oncology Biometrics at Pfizer, having taken on this role in 2023. Previously, Biao held the position of Executive Director of Biostatistics at Seagen from 2019 to 2023 and was the Head of Biostatistics, Statistical Programming and Data Management at Dynavax Technologies from 2016 to 2019. Biao's extensive experience in biostatistics is complemented by roles at notable companies, including Gilead Sciences, Onyx Pharmaceuticals, and Sanofi. Biao earned a Ph.D. in Biostatistics from the University of California, Berkeley in 2004 and is currently pursuing a Bachelor of Arts at Peking University.
This person is not in any teams
This person is not in any offices